Latest filing published 03 Dec 2024 for FILANA THERAPEUTICS, INC., €7,233.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -32.4%Entry US$25.72 · Close at T+365 US$17.39
- +379.2%Entry US$10.07 · Close at T+365 US$48.26
- +248.0%Entry US$2.25 · Close at T+365 US$7.83
- +98.1%Entry US$1.07 · Close at T+365 US$2.12
- -12.0%Entry US$25.05 · Close at T+365 US$22.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eric Schoen: trading record in brief
Filings by Eric Schoen span 2 companies, the busiest being Filana Therapeutics, Inc. and Aspira Women's Health Inc. The record holds 13 filings, for trades running from 15 November 2011 to 29 November 2024.
In open-market terms, that means 9 purchases worth €165k on one side and 2 sales worth €226k on the other. Netting one side against the other leaves €61k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 option exercises. Since January 2024: no purchases and 2 sales on the market.
The median purchase comes to €8,964. On 5 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 9 purchases show a median change of +3.0%, with the price up in 56% of them. This is a record of the past, not a forecast.
Most recently, on 3 December 2024, the filings show an open-market sale worth €7,233 in Filana Therapeutics, Inc. The most recent open-market purchase was published on 16 August 2022, 1,546 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Schoen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$3.821.6% of flowCommon StockSEC:0001437749-24-036546:1
- 59,800 shares@ US$3.8648.5% of flowCommon StockSEC:0001437749-24-036546:2
- 50,000 shares@ US$1.1841.3% of flowCommon StockSEC:0001437749-24-036546:0
- 1,500 shares@ US$22.0022.9% of flowCommon StockSEC:0001437749-24-012331:0
- 2,500 shares@ US$19.9535.8% of flowCommon StockSEC:0001069530-22-000037:0Canonical exit: 10 Nov 2022 (T+90)
- 10,000 shares@ US$7.0328.8% of flowCommon StockSEC:0001069530-20-000057:0Canonical exit: 16 Dec 2020 (T+90)
- 2,000 shares@ US$7.045.8% of flowCommon StockSEC:0001069530-20-000057:1Canonical exit: 16 Dec 2020 (T+90)
- 5,300 shares@ US$1.884.0% of flowCommon StockSEC:0001069530-19-000063:0Canonical exit: 18 Mar 2020 (T+90)
- 10,000 shares@ US$1.064.2% of flowCommon StockSEC:0001069530-19-000030:0Canonical exit: 12 Aug 2019 (T+90)
- 3,347 shares@ US$1.40100.0% of flowCommon Stock, par value $0.001SEC:0001532303-17-000001:0Canonical exit: 14 May 2017 (T+90)
- 5,000 shares@ US$1.42Common StockSEC:0001532303-14-000002:0Canonical exit: 16 Feb 2015 (T+90)
- 10,000 shares@ US$1.19Common StockSEC:0001532303-11-000001:0Canonical exit: 13 Feb 2012 (T+90)
- 9,525 shares@ US$1.17Common StockSEC:0001532303-11-000001:1Canonical exit: 13 Feb 2012 (T+90)
13 of 13 declarations
